EUVIMEDEUVIMED entdecken
Open Access

Matrix bound nanovesicle-associated IL-33 activates a pro-remodeling macrophage phenotype via a non-canonical, ST2-independent pathway

George S Hussey, Jenna L Dziki, Yoojin C Lee, Joseph G Bartolacci, Marissa Behun, Hēth R Turnquist, Stephen F Badylak

Journal of Immunology and Regenerative Medicine · 2019

DOI: 10.1016/j.regen.2019.01.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology and Regenerative Medicine, 2019. Verfasst von George S Hussey und 6 weiteren Autor:innen. Beteiligte Einrichtung: McGowan Institute for Regenerative Medicine, University of Pittsburgh, 450 Technology Drive, Suite 300, Pittsburgh, PA 15219-3110, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The regenerative healing response of injured skeletal muscle is dependent upon an appropriately timed switch from a local type-I to a type-II immune response. Biologic scaffolds derived from extracellular matrix (ECM) have been shown to facilitate a macrophage phenotype transition that leads to downstream site-appropriate functional tissue deposition and myogenesis. However, the mechanisms by which ECM directs the switching of immune cell phenotype are only partially understood. Herein, we provide the first evidence that matrix bound nanovesicles (MBV) embedded within ECM-scaffolds are a rich and stable source of interleukin-33 (IL-33), an alarmin/cytokine with emerging reparative properties. We show that IL-33 encapsulated within MBV bypass the classical IL33/ST2 receptor signaling pathway to direct macrophage differentiation into the reparative, pro-remodeling M2 phenotype, which in turn facilitates myogenesis of skeletal muscle progenitor cells. Our results suggest the potential of IL-33+ MBV as a clinical therapy to augment the restorative efficacy of existing ECM-based and non-ECM based approaches.

Schlagwörter

Stichwörter der Autor:innen

Extracellular MatrixInterleukin-33Macrophage polarizationMatrix bound nanovesicles

Autor:innen und Institutionen

  • McGowan Institute for Regenerative Medicine, University of Pittsburgh, 450 Technology Drive, Suite 300, Pittsburgh, PA 15219-3110, USA.
  • Department of Surgery, School of Medicine, University of Pittsburgh, University of Pittsburgh Medical Center Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
  • Department of Bioengineering, University of Pittsburgh, 3700 O'Hara Street, Pittsburgh, PA, 15261, USA.
  • Thomas E. Starzl Transplantation Institute, University of Pittsburgh, University of Pittsburgh Medical Center Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
  • Department of Immunology, School of Medicine, University of Pittsburgh, University of Pittsburgh Medical Center Presbyterian Hospital, 200 Lothrop Street, Pittsburgh, PA 15213, USA.

Förderung

  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • NIBIB NIH HHS
  • NIH

Zitieren

APA

Hussey, G. S., Dziki, J. L., Lee, Y. C., Bartolacci, J. G., Behun, M., Turnquist, H. R., & Badylak, S. F. (2019). Matrix bound nanovesicle-associated IL-33 activates a pro-remodeling macrophage phenotype via a non-canonical, ST2-independent pathway. Journal of Immunology and Regenerative Medicine. https://doi.org/10.1016/j.regen.2019.01.001

Vancouver

Hussey GS, Dziki JL, Lee YC, Bartolacci JG, Behun M, Turnquist HR, et al. Matrix bound nanovesicle-associated IL-33 activates a pro-remodeling macrophage phenotype via a non-canonical, ST2-independent pathway. Journal of Immunology and Regenerative Medicine. 2019. doi:10.1016/j.regen.2019.01.001

BibTeX
@article{Hussey2019,
  author = {Hussey, George S and Dziki, Jenna L and Lee, Yoojin C and Bartolacci, Joseph G and Behun, Marissa and Turnquist, Hēth R and Badylak, Stephen F},
  title = {Matrix bound nanovesicle-associated IL-33 activates a pro-remodeling macrophage phenotype via a non-canonical, ST2-independent pathway},
  journal = {Journal of Immunology and Regenerative Medicine},
  year = {2019},
  doi = {10.1016/j.regen.2019.01.001}
}
Kostenlos starten →